Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction

Journal of Cardiovascular Magnetic Resonance

Volumn 14, Issue 1, 2012, Pages

  Ellims, Andris H ^a,b   Iles, Leah M ^a,b   Ling, Liang Han ^a,b   Hare, James L ^a,b   Kaye, David M ^a,b   Taylor, Andrew J ^a,b  

^a ALFRED HOSPITAL   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Hypertrophic cardiomyopathy; Magnetic resonance imaging; Myocardial fibrosis; T1 mapping

Indexed keywords

GADOLINIUM PENTETATE MEGLUMINE; CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM PENTETATE;

ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART MUSCLE FIBROSIS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TRANSTHORACIC ECHOCARDIOGRAPHY; ADULT; AGED; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; DIASTOLE; ECHOGRAPHY; FIBROSIS; HEART MUSCLE; HEART STROKE VOLUME; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; STATISTICAL MODEL; TIME;

ADULT; AGED; CARDIOMYOPATHY, HYPERTROPHIC; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; DIASTOLE; FEMALE; FIBROSIS; GADOLINIUM DTPA; HUMANS; LINEAR MODELS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; STROKE VOLUME; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84867901815     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-14-76     Document Type: Article

References (38)

1. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spirito P, Ten Cate FJ, Wigle ED, Spencer WH 3rd, J Am Coll Cardiol 2003 42 1687 1713 10.1016/S0735-1097(03)00941-0 14607462 (Pubitemid 37383745)
2. Hypertrophic cardiomyopathy: a systematic review. Maron BJ, JAMA 2002 287 1308 1320 10.1001/jama.287.10.1308 11886323 (Pubitemid 34250486)
3. The molecular genetic basis for hypertrophic cardiomyopathy. Marian AJ, Roberts R, J Mol Cell Cardiol 2001 33 655 670 10.1006/jmcc.2001.1340 11273720 (Pubitemid 32538979)
4. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Seidman JG, Seidman C, Cell 2001 104 557 567 10.1016/S0092-8674(01)00242-2 11239412 (Pubitemid 32201950)
5. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. Maron BJ, Spirito P, Shen WK, Haas TS, Formisano F, Link MS, Epstein AE, Almquist AK, Daubert JP, Lawrenz T, et al. JAMA 2007 298 405 412 10.1001/jama.298.4.405 17652294 (Pubitemid 47124061)
6. Management of symptoms in hypertrophic cardiomyopathy. Fifer MA, Vlahakes GJ, Circulation 2008 117 429 439 10.1161/CIRCULATIONAHA.107.694158 18212300
7. Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease. Varnava AM, Elliott PM, Sharma S, McKenna WJ, Davies MJ, Heart 2000 84 476 482 10.1136/heart.84.5.476 11040002
8. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. Mewton N, Liu CY, Croisille P, Bluemke D, Lima JA, J Am Coll Cardiol 2011 57 891 903 10.1016/j.jacc.2010.11.013 21329834
9. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM, N Engl J Med 2000 343 1445 1453 10.1056/NEJM200011163432003 11078769
10. Gadolinium-enhanced magnetic resonance imaging in hypertrophic cardiomyopathy: in vivo imaging of the pathologic substrate for premature cardiac death? Kim RJ, Judd RM, J Am Coll Cardiol 2003 41 1568 1572 10.1016/S0735-1097(03)00190-6 12742299 (Pubitemid 36543377)
11. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. O'Hanlon R, Grasso A, Roughton M, Moon JC, Clark S, Wage R, Webb J, Kulkarni M, Dawson D, Sulaibeekh L, et al. J Am Coll Cardiol 2010 56 867 874 10.1016/j.jacc.2010.05.010 20688032
12. Magnetic resonance imaging of myocardial fibrosis in hypertrophic cardiomyopathy. Wilson JM, Villareal RP, Hariharan R, Massumi A, Muthupillai R, Flamm SD, Tex Heart Inst J 2002 29 176 180 12224720 (Pubitemid 35006923)
13. Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy. Teraoka K, Hirano M, Ookubo H, Sasaki K, Katsuyama H, Amino M, Abe Y, Yamashina A, Magn Reson Imaging 2004 22 155 161 10.1016/j.mri.2003.08.009 15010107 (Pubitemid 38326634)
14. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy. Rubinshtein R, Glockner JF, Ommen SR, Araoz PA, Ackerman MJ, Sorajja P, Bos JM, Tajik AJ, Valeti US, Nishimura RA, Gersh BJ, Circ Heart Fail 2010 3 51 58 10.1161/CIRCHEARTFAILURE.109.854026 19850699
15. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. Choudhury L, Mahrholdt H, Wagner A, Choi KM, Elliott MD, Klocke FJ, Bonow RO, Judd RM, Kim RJ, J Am Coll Cardiol 2002 40 2156 2164 10.1016/S0735-1097(02)02602-5 12505229 (Pubitemid 36005903)
16. The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance. Noureldin RA, Liu S, Nacif MS, Judge DP, Halushka MK, Abraham TP, Ho C, Bluemke DA, J Cardiovasc Magn Reson 2012 14 17 10.1186/1532-429X-14-17 22348519
17. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. Iles L, Pfluger H, Phrommintikul A, Cherayath J, Aksit P, Gupta SN, Kaye DM, Taylor AJ, J Am Coll Cardiol 2008 52 1574 1580 10.1016/j.jacc.2008.06.049 19007595
18. Association between diffuse myocardial fibrosis by cardiac magnetic resonance contrast-enhanced T mapping and subclinical myocardial dysfunction in diabetic patients: a pilot study. Ng AC, Auger D, Delgado V, van Elderen SG, Bertini M, Siebelink HM, van der Geest RJ, Bonetti C, van der Velde ET, de Roos A, et al. Circ Cardiovasc Imaging 2012 5 51 59 10.1161/CIRCIMAGING.111.965608 22135399
19. Contrast-enhanced myocardial T1-weighted scout (Look-Locker) imaging for the detection of myocardial damages in hypertrophic cardiomyopathy. Amano Y, Takayama M, Kumita S, J Magn Reson Imaging 2009 30 778 784 10.1002/jmri.21921 19787718
20. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Flett AS, Hayward MP, Ashworth MT, Hansen MS, Taylor AM, Elliott PM, McGregor C, Moon JC, Circulation 2010 122 138 144 10.1161/CIRCULATIONAHA.109.930636 20585010
21. Detection of acutely impaired microvascular reperfusion after infarct angioplasty with magnetic resonance imaging. Taylor AJ, Al-Saadi N, Abdel-Aty H, Schulz-Menger J, Messroghli DR, Friedrich MG, Circulation 2004 109 2080 2085 10.1161/01.CIR.0000127812.62277.50 15117844 (Pubitemid 38620215)
22. Fast, three-dimensional free-breathing MR imaging of myocardial infarction: a feasibility study. Saranathan M, Rochitte CE, Foo TK, Magn Reson Med 2004 51 1055 1060 10.1002/mrm.20061 15122690 (Pubitemid 38580620)
23. Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy. Maron MS, J Cardiovasc Magn Reson 2012 14 13 10.1186/1532-429X-14-13 22296938
24. Late gadolinium enhancement on cardiac magnetic resonance and phenotypic expression in hypertrophic cardiomyopathy. Conte MR, Bongioanni S, Chiribiri A, Leuzzi S, Lardone E, Di Donna P, Pizzuti A, Luceri S, Cesarani F, Mabritto B, et al. Am Heart J 2011 161 1073 1077 10.1016/j.ahj.2011.03.022 21641353
25. Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy. Green JJ, Berger JS, Kramer CM, Salerno M, JACC Cardiovasc Imaging 2012 5 370 377 10.1016/j.jcmg.2011.11.021 22498326
26. Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy. Maron MS, Appelbaum E, Harrigan CJ, Buros J, Gibson CM, Hanna C, Lesser JR, Udelson JE, Manning WJ, Maron BJ, Circ Heart Fail 2008 1 184 191 10.1161/CIRCHEARTFAILURE.108.768119 19808288
27. Diastolic tissue Doppler indexes correlate with the degree of collagen expression and cross-linking in heart failure and normal ejection fraction. Kasner M, Westermann D, Lopez B, Gaub R, Escher F, Kuhl U, Schultheiss HP, Tschope C, J Am Coll Cardiol 2011 57 977 985 10.1016/j.jacc.2010.10.024 21329845
28. Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy. Nagueh SF, Lakkis NM, Middleton KJ, Spencer WH 3rd, Zoghbi WA, Quinones MA, Circulation 1999 99 254 261 10.1161/01.CIR.99.2.254 9892592 (Pubitemid 29056368)
29. Evaluation of left ventricular filling pressures by Doppler echocardiography in patients with hypertrophic cardiomyopathy: correlation with direct left atrial pressure measurement at cardiac catheterization. Geske JB, Sorajja P, Nishimura RA, Ommen SR, Circulation 2007 116 2702 2708 10.1161/CIRCULATIONAHA.107.698985 18025528 (Pubitemid 350291242)
30. Left ventricular diastolic function assessed using Doppler tissue imaging in patients with hypertrophic cardiomyopathy: relation to symptoms and exercise capacity. Matsumura Y, Elliott PM, Virdee MS, Sorajja P, Doi Y, McKenna WJ, Heart 2002 87 247 251 10.1136/heart.87.3.247 11847164 (Pubitemid 34177680)
31. American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy: Endorsed by the American Society of Nuclear Cardiology, Society for Cardiovascular Magnetic Resonance, and Society of Cardiovascular Computed Tomography. Nagueh SF, Bierig SM, Budoff MJ, Desai M, Dilsizian V, Eidem B, Goldstein SA, Hung J, Maron MS, Ommen SR, Woo A, J Am Soc Echocardiogr 2011 24 473 498 10.1016/j.echo.2011.03.006 21514501
32. Aldosterone induces a vascular inflammatory phenotype in the rat heart. Rocha R, Rudolph AE, Frierdich GE, Nachowiak DA, Kekec BK, Blomme EA, McMahon EG, Delyani JA, Am J Physiol Heart Circ Physiol 2002 283 1802 1810 12384457
33. Assessment of diffuse myocardial fibrosis in rats using small-animal Look-Locker inversion recovery T1 mapping. Messroghli DR, Nordmeyer S, Dietrich T, Dirsch O, Kaschina E, Savvatis K, Oh-I D, Klein C, Berger F, Kuehne T, Circ Cardiovasc Imaging 2011 4 636 640 10.1161/CIRCIMAGING.111.966796 21917782
34. Association of imaging markers of myocardial fibrosis with metabolic and functional disturbances in early diabetic cardiomyopathy. Jellis C, Wright J, Kennedy D, Sacre J, Jenkins C, Haluska B, Martin J, Fenwick J, Marwick TH, Circ Cardiovasc Imaging 2011 4 693 702 10.1161/CIRCIMAGING.111.963587 21946703
35. Myocardial T1 mapping for detection of left ventricular myocardial fibrosis in chronic aortic regurgitation: pilot study. Sparrow P, Messroghli DR, Reid S, Ridgway JP, Bainbridge G, Sivananthan MU, AJR Am J Roentgenol 2006 187 630 635 10.2214/AJR.05.1264 17114517
36. Acute left ventricular remodeling following myocardial infarction: coupling of regional healing with remote extracellular matrix expansion. Chan W, Duffy SJ, White DA, Gao XM, Du XJ, Ellims AH, Dart AM, Taylor AJ, JACC Cardiovasc Imaging 2012 5 884 893 10.1016/j.jcmg.2012.03.015 22974800
37. T2-weighted cardiovascular magnetic resonance imaging. Abdel-Aty H, Simonetti O, Friedrich MG, J Magn Reson Imaging 2007 26 452 459 10.1002/jmri.21028 17729358 (Pubitemid 350194566)
38. Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance. Ferreira VM, Piechnik SK, Dall'armellina E, Karamitsos TD, Francis JM, Choudhury RP, Friedrich MG, Robson MD, Neubauer S, J Cardiovasc Magn Reson 2012 14 42 10.1186/1532-429X-14-42 22720998